PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. (1) There shall be no dissemination or publication, except within and between the Performer and any subcontractors, of information developed under this Agreement or contained in the reports to be furnished pursuant to this Agreement without prior written approval of the AOR. All technical reports will be given proper review by appropriate authority to determine which Distribution Statement is to be applied prior to the initial distribution of these reports by the Performer. Unclassified patent related documents are exempt from prepublication controls and this review requirement. There shall be no dissemination or publication, except within and between the Performer and any subcontractor(s), of information developed under this effort without first obtaining approval for public release from the DARPA Public Release Center (PRC). Papers prepared in response to academic requirements which are not intended for public release outside the academic institution are exempt from prepublication controls.
(2) The Performer shall submit all proposed public releases for review and approval as instructed at xxxx://xxx.xxxxx.xxx/work-with-us/contract-management/public-release. Public releases include press releases, specific publicity or advertisement, and publication or presentation, but exclude those relating to the open sourcing or licensing, sales or other commercial exploitation of products, services or technologies. In addition, articles for publication or presentation will contain a statement on the title page worded substantially as follows: This research was, in part, funded by the U.S. Government. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. Prohibition Public Release
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. There shall be no public dissemination or publication of information developed under this Agreement or contained in the reports to be furnished pursuant to this Agreement without prior written approval of the AOR or the Government PM. All technical reports will be given proper review by appropriate authority to determine which Distribution Statement is to be applied prior to the initial public distribution of these reports by the Performer. Unclassified patent related documents are exempt from prepublication controls and this review requirement. Dissemination or publication of information developed under this effort that has national security implications must be first approved in writing by the Program Manager if release is contemplated to foreign governments or companies. For greater certainty and notwithstanding the foregoing, dissemination of information developed under this Agreement that is not of national security implications and not specifically applicable to Government facilities, equipment, or interests to Performer’s existing or potential subcontractors, partners, vendors, suppliers or customers shall not be considered public dissemination or publication subject to the prepublication controls and review requirements noted herein. The Performer shall deliver all proposed public releases for review and approval to the AO who will coordinate with AF public affairs. Public releases include press releases, specific publicity or advertisement, and publication or presentation, but exclude those relating to the open sourcing or licensing, sales or other commercial exploitation of products, services or technologies. In addition, articles for publication or presentation will contain a statement on the title page worded substantially as follows: This research was, in part, funded by the U.S. Government. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. 1. Except with regard to subcontractors, team members, or other program participants, the Performer agrees to restrict dissemination or publication of information developed or generated under this Agreement without prior written approval by DARPA.
2. The following information or documents will not be subject to requirements of Section 1 of this Article.
(a) Unclassified information or documents used in the patent process, copyright approval process, or trademark approval process,
(b) Papers prepared in response to academic requirements which are not intended for public release outside the academic institution, or
(c) Information or documents related to program activities that have been determined to be fundamental research.
3. The Performer shall submit any proposed public releases that reference the United States Government, the Department of Defense, or DARPA in any form or references the program name or the names of any government staff for review and approval as instructed at xxxx://xxx.xxxxx.xxx/work-with-us/contract-management/public-release. Public releases may include press releases, specific publicity or advertisement, and publication or presentation, but excludes those relating to open sourcing or licensing, sales or other commercial exploitation of products, services, or technologies. In addition, articles for publication or presentation that mention DARPA in any form or the name of the program will contain a statement on the title page worded substantially as follows:\ “This research was funded, in part, by the U.S. Government. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government.” [THIS ARTICLE MAY BE AMENDED TO IDENTIFY FUNDAMENTAL RESEARCH BEING CONDUCTED BY UNVERSITY SUBCONTRACTORS, IF APPLICABLE, AND THAT SUCH EFFORTS WILL BE SUBJECT TO GOVERNMENT PUBLICATION REVIEW AND APPROVAL]
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. There shall be no dissemination or publication, except within and between the Performer and any subcontractors, of information developed under this Agreement or contained in the reports to be furnished pursuant to this Agreement without prior written approval of the AO. Unclassified patent related documents are exempt from prepublication controls and this review requirement.
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. There shall be no dissemination or publication regarding the work performed under this Agreement without prior written approval by AstraZeneca.
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. (1) There shall be no dissemination or publication, except within and between The Boeing Company and any subcontractors, of information developed under this Agreement or contained in the reports to be furnished pursuant to this Agreement without prior written approval of the AOR. All technical reports will be given proper review by appropriate authority to determine which Distribution Statement is to be applied prior to the initial distribution of these reports by the Seller. Unclassified patent related documents are exempt from prepublication controls and this review requirement. Papers resulting from unclassified fundamental research are exempt from prepublication controls and this review requirement, pursuant to DoD Instruction 5230.27 dated October 6, 1987.
(2) The Seller shall submit all proposed public releases for review and approval as instructed at xxxx://xxx.xxxxx.xxx/prc/. Public releases include press releases, specific publicity or advertisement, and publication or presentation, but exclude those relating to the open sourcing or licensing, sales or other commercial exploitation of products, services or technologies. In addition, articles for publication or presentation will contain a statement on the title page worded substantially as follows:
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. At this time, MEDIMMUNE expects the work performed under this Agreement will NOT be fundamental research, and it is, therefore, subject to the following publication restrictions: There shall be no dissemination or publication regarding the work performed under this Agreement without prior written approval by MEDIMMUNE.
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. Any publications regarding this contract or the work and research it involves require prior written consent from Buyer. If publishing is approved, it is subject to guidelines and requirements below. Seller shall assure that an acknowledgment of Government support will appear on each publication or presentation of any material based upon or developed under this contract. A statement shall appear on the title page worded substantially as follows: “This research was partially funded by the Government under Agreement No. W911W6-18-2-0004. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation thereon.” Seller is responsible for assuring that every publication of material based on or developed under this contract contains the following disclaimer: “The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Aviation Development Directorate, Aviation Applied Technology Directorate or the U.S. Government.” In addition, all Press Releases must include the below language at the end of the document. "U.S. Army Aviation and Missile Research, Development, and Engineering Center provides increased responsiveness to the nation’s Warfighters through aviation and missile capabilities and life cycle engineering solutions."
PUBLIC RELEASE OR DISSEMINATION OF INFORMATION. 1. There shall be no dissemination or publication, except within and between the Performer and any subcontractors, of information developed under this Agreement or contained in the reports to be furnished pursuant to this Agreement without prior written approval of the AOR/PM. All technical reports will be given proper review by appropriate authority to determine which Distribution Statement is to be applied prior to the initial distribution of these reports by the Performer. Unclassified patent related documents are exempt from prepublication controls and this review requirement. Papers resulting from unclassified fundamental research are exempt from prepublication controls and this review requirement, pursuant to DoD Instruction 5230.27 dated October 6, 1987.
2. The Performer shall submit all proposed public releases for review and approval as instructed at xxxx://xxx.xxxxx.xxx/NewsEvents/Public_Release_Center/Public_Release_Center.aspx /. Public releases include press releases, specific publicity or advertisement, and publication or presentation, but exclude those relating to the open sourcing or licensing, sales or other commercial exploitation of products, services or technologies. In addition, articles for publication or presentation will contain a statement on the title page worded substantially as follows: “This research was, in part, funded by the U.S. Government. The views and conclusions contained in this document are those of the authors and should not be interpreted
